Chugai Pharmaceutical
4519.T
$29.08
Share price
1.15%
Change (1 day)
6.36%
Change (1 year)
Categories
Revenue for Chugai Pharmaceutical (4519.T)
Revenue in 2023 (TTM): $9.10 B
According to Chugai Pharmaceutical's latest financial reports the company's current revenue (TTM) is $9.10 B. In 2022 the company made a revenue of $9.59 B an increase over the years 2021 revenue that were of $8.90 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Chugai Pharmaceutical from 2009 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $9.10 B | -5.09% |
| 2022 | $9.59 B | 7.75% |
| 2021 | $8.90 B | 19.83% |
| 2020 | $7.42 B | 17.95% |
| 2019 | $6.29 B | 19.67% |
| 2018 | $5.26 B | 10.62% |
| 2017 | $4.75 B | 4.54% |
| 2016 | $4.55 B | 10.14% |
| 2015 | $4.13 B | -2.98% |
| 2014 | $4.25 B | -0.19% |
| 2013 | $4.26 B | -10.79% |
| 2012 | $4.78 B | 1.45% |
| 2011 | $4.71 B | 7.23% |
| 2010 | $4.39 B | -3.59% |
| 2009 | $4.56 B |